Stockscreener 앱 받기
5.72
0.53%
0.03
시장 영업 전:
5.84
0.12
+2.10%
전일 마감가:
$5.69
열려 있는:
$5.78
하루 거래량:
1.92M
Relative Volume:
0.76
시가총액:
$929.54M
수익:
-
순이익/손실:
$-206.69M
주가수익비율:
-4.2198
EPS:
-1.3555
순현금흐름:
$-186.49M
1주 성능:
-4.67%
1개월 성능:
+4.00%
6개월 성능:
+90.03%
1년 성능:
+216.02%
1일 변동 폭
$5.635
$5.88
1주일 범위
$5.62
$6.065
52주 변동 폭
$1.60
$7.18
아넥손 Stock (ANNX) Company Profile
명칭
Annexon Inc
전화
(650) 822-5500
주소
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
5.72 | 929.54M | 0 | -206.69M | -186.49M | -1.3555 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
아넥손 Stock (ANNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-23 | 개시 | Chardan Capital Markets | Buy |
| 2024-03-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-10-30 | 개시 | Wells Fargo | Overweight |
| 2023-05-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-05-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-09-16 | 개시 | Jefferies | Buy |
| 2022-09-09 | 개시 | BTIG Research | Buy |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-09-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-01-26 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | BofA Securities | Buy |
| 2020-08-18 | 개시 | Cowen | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
모두보기
아넥손 주식(ANNX)의 최신 뉴스
ANNX Earnings History & Surprises | EPS & Revenue Results | ANNEXON INC (NASDAQ:ANNX) - ChartMill
Wall Street analysts see a 165.52% upside in Annexon (ANNX): Can the stock really move this high? - MSN
Annexon | DEFA14A: Others - Moomoo
Annexon | ARS: Annual Report to Security Holders - Moomoo
ANNX: Late-stage C1q inhibitors show strong efficacy in GBS and GA, with pivotal data due in 2026 - TradingView
Annexon (NASDAQ: ANNX) proxy asks approval to boost share authorization and elect directors - Stock Titan
Annexon stock rises after director purchases shares - MSN
Annexon presents four studies on Guillain-Barre syndrome disease burden and targeted therapies - Traders Union
Annexon (ANNX): 7 Small Cap Stocks with the Highest Upside Potential - Insider Monkey
Annexon Biosciences Stock Surges 289 Percent Amid Clinical Progress - HarianBasis.co
Annexon Biosciences (ANNX) Buy Rating Retained - Insider Monkey
Annexon, Inc. (NASDAQ:ANNX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Does Annexon’s 2026 “Win Year” Milestone Roadmap Reshape The Bull Case For Annexon (ANNX)? - simplywall.st
Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Annexon Biosciences (ANNX) and UnitedHealth (UNH) - The Globe and Mail
Annexon (NASDAQ: ANNX) seeks vote to increase authorized shares to 500M - Stock Titan
Needham Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Annexon | PRE 14A: Preliminary proxy statements relating to merger or acquisition - Moomoo
Annexon CEO Touts “Win Year” 2026 at Needham, Eyes GA Phase III Data and GBS FDA Filing - Yahoo Finance
Annexon (NASDAQ:ANNX) Trading 8.5% Higher Following Insider Buying Activity - MarketBeat
Carson buys $49k in Annexon (ANNX) stock - Investing.com
Insider Buying: Annexon (NASDAQ:ANNX) Director Purchases 8,000 Shares of Stock - MarketBeat
Carson buys $49k in Annexon (ANNX) stock By Investing.com - Investing.com India
Annexon (NASDAQ: ANNX) director adds 8,000 shares in planned stock purchase - Stock Titan
EV Market: Will Annexon Inc benefit from government policyWall Street Watch & Technical Buy Zone Confirmation - baoquankhu1.vn
Annexon (NASDAQ:ANNX) Shares Down 6.1%Here's Why - MarketBeat
Is Annexon (ANNX) Stock Undervalued Now | ANNX Q4 Earnings: Beats Estimates by $0.04PEG Ratio - Cổng thông tin điện tử tỉnh Lào Cai
Macro Review: Will Annexon Inc benefit from government policyPortfolio Gains Summary & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference - Bitget
Geopolitics Watch: What are the risks of holding Annexon Inc2026 Analyst Calls & Long-Term Investment Growth Plans - baoquankhu1.vn
Annexon (NASDAQ:ANNX) Shares Up 6.6%What's Next? - MarketBeat
HC Wainwright Estimates Annexon FY2030 Earnings - MarketBeat
Annexon posts full-year 2025 financial results and portfolio updates - Traders Union
아넥손 (ANNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):